SBIR/STTR Reauthorization Act of 2025
- Sponsor
- Sen. Markey, Edward J. [D-MA]
- Committees
- Small Business and Entrepreneurship Committee (primary)
- Last action
- May 1, 2025
Bottom line
This bill reauthorizes and significantly expands the SBIR and STTR programs, aiming to boost small business innovation, commercialization, and participation from underrepresented groups, while also enhancing oversight and addressing national security risks related to foreign ownership.
What it actually does
This bill reauthorizes the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, significantly increasing the percentage of federal agency research and development budgets allocated to them over time. It introduces new provisions to enhance competition, improve commercialization, and strengthen oversight, including targeted outreach to underrepresented groups, expanded technical assistance, and new safeguards against foreign ownership of award recipients. The bill also extends several pilot programs and mandates new reporting requirements for federal agencies.
Proponents argue
Proponents argue that the bill is essential for fostering innovation, supporting small businesses, and maintaining U.S. competitiveness in critical technology sectors. They contend that increasing funding allocations, enhancing commercialization support, and broadening participation will lead to more breakthroughs, create jobs, and ensure federal research dollars reach a diverse array of innovative companies. The national security provisions are seen as vital to protect sensitive research from foreign adversaries.
Opponents contend
Critics, if any, might raise concerns about the substantial increase in mandated set-asides, arguing it could reduce federal agencies' flexibility in allocating R&D funds to established research channels or larger contractors. Some may also express apprehension about the administrative burden associated with new reporting requirements, enhanced outreach, and stringent foreign ownership checks, potentially slowing down the award process or deterring legitimate investment.
The bill is moderately complex due to its numerous amendments to existing law and multiple titles/sections, requiring careful reading to understand the full scope of changes to the SBIR/STTR programs.
Sec. 101
Reauthorization of SBIR and STTR Programs
This section extends the authority for the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, ensuring their continued operation beyond their current expiration in fiscal year 2025. This provides long-term stability for these federal programs that fund small business research and development.
Supporters argue
Proponents argue that extending these programs is crucial for maintaining a pipeline of innovative technologies and supporting the growth of small businesses in critical sectors, ensuring continuity in federal R&D investment.
Critics contend
No specific opposition is typically raised against the general reauthorization of these programs, though debates often occur over the specific terms and funding levels of reauthorization.
Tradeoffs
The primary tradeoff is ensuring long-term program stability versus the opportunity for periodic legislative review and adjustment of program parameters.
Sec. 201
Increased Agency Expenditures for SBIR and STTR Programs
This provision mandates a gradual increase in the percentage of federal agencies' extramural research and development budgets that must be allocated to the SBIR and STTR programs. For SBIR, the allocation rises from 3.2% (FY2017-2025) to 7% by fiscal year 2032 and thereafter. For STTR, it increases from 0.45% (FY2016-2025) to 1% by fiscal year 2032 and thereafter.
Sec. 202
SBIR and STTR Fellowships
This section authorizes federal agencies to provide grants or awards for fellowship and internship opportunities (undergraduate, baccalaureate, graduate, and postdoctoral levels) at small businesses that have received Phase II SBIR or STTR awards. It also requires enhanced outreach for these opportunities to women, socially disadvantaged individuals, and economically disadvantaged individuals, and allows agencies to partner with non-profit organizations for this outreach.
Sec. 204
Technical and Business Assistance (TABA) Improvements
This section significantly modifies the Technical and Business Assistance (TABA) program. It authorizes SBIR/STTR award recipients to select their own vendors for TABA services (including cybersecurity assistance), rather than being limited to agency-selected vendors. It also allows recipients to use TABA funds to hire or augment staff for training activities. The maximum TABA funding is increased to $6,500 for Phase I projects and $50,000 for Phase II projects. Additionally, federal agencies are required to offer participation in I-Corps programs to award recipients.
Sec. 303
Designation of Technology Commercialization Official
This section requires the head of each federal agency with an SBIR or STTR program to designate an existing official as a Technology Commercialization Official (TCO). The TCO will be responsible for providing guidance to awardees on commercialization, coordinating with other TCOs, submitting annual reports on commercialization activities, advocating for Phase III awards, and reporting on efforts to simplify application processes and requirements.
Sec. 401
Extension and Modification of Administrative Funds
This section extends the authority for federal agencies to use up to 3.3% (up from 3%) of their SBIR/STTR funds for administrative, oversight, and contract processing costs until September 30, 2030. Crucially, it mandates that major agencies (DoD, DoE, HHS, NASA, NSF) transfer at least 10% of these administrative funds to the Small Business Administration (SBA) to increase SBA's resources for administering the SBIR and STTR programs.
Sec. 402
Expansion of Direct to Phase II Authority
This section extends the 'Direct to Phase II' authority until 2030 and expands its applicability from only the National Institutes of Health (NIH), Department of Defense (DoD), and Department of Education to all federal agencies required to carry out an SBIR program. It sets limits on the total value of such awards: not more than 10% of an agency's total SBIR funds (15% for NIH) in a fiscal year. Agencies must also report on the number and amount of these awards.
Sec. 504
NIH Pilot Program to Accelerate SBIR/STTR Awards
This section establishes a pilot program at the National Institutes of Health (NIH) to reduce the time for SBIR/STTR awards, aiming for a 90-day turnaround from notice to funding release. The pilot allows NIH to use flexible peer review procedures, including consultation with appropriate scientific experts, which are deemed to fulfill existing Public Health Service Act requirements for merit review. The pilot program is set to terminate on September 30, 2030, with an evaluation report due in three years.
Sec. 505
Safeguards Against Foreign Entity Ownership
This section codifies safeguards by making small businesses majority-owned by multiple venture capital operating companies, hedge funds, or private equity firms ineligible for SBIR awards if the SBA Administrator determines they are, or are majority-owned/controlled by, a 'covered foreign entity.' It defines 'covered foreign entity' broadly, including foreign entities of concern (e.g., designated terrorist organizations, sanctioned entities, entities from covered nations, or those involved in espionage), foreign governments, and non-resident natural persons, along with any entities or individuals controlled by or acting on behalf of such entities.
Sec. 506
Annual Commercialization Impact Assessment
This section requires the SBA Administrator, in coordination with federal agencies, to develop an annual commercialization impact assessment. This assessment will measure various metrics for small businesses that have received at least 50 Phase II awards, including total federal awards, SBIR/STTR awards, gross revenue, revenue from product/service sales/licensing, additional investments, mergers/acquisitions, spin-out companies, employee numbers, and Phase III awards. The findings will be reported to Congress and published.
Requires detailed reporting on research institutions subcontracted by SBIR/STTR award recipients, including their name, location, type (e.g., institution of higher education, nonprofit, federally funded R&D center), and for higher education institutions, specific classifications such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribal Colleges or Universities, etc. This applies to Phase I, II, and III awards.
Sec. 205(a)(3)(D) and (b)(3)(D) and Sec. 9(k)(1)(B)(iv) and (2)(H)
Why it matters:This level of detail is typical for legislative language amending existing statutes to add specific data collection fields. It's standard legislative practice to ensure precise implementation.
Case for: Supporters argue that this granular data collection will significantly enhance transparency regarding how federal R&D funds flow to various research institutions, allowing for better analysis of program reach, diversity of partnerships, and impact on different educational sectors.
Case against: Federal agencies might face a considerable administrative burden in collecting, verifying, and publishing such detailed and specific institutional data, potentially requiring new data systems or processes.
Estimated impact: This will lead to a substantial increase in publicly available data on federal R&D subcontracting, enabling more comprehensive oversight and analysis of program equity and reach.
Mandates that not less than 10% of the administrative funds used by the Department of Defense, Department of Energy, Department of Health and Human Services, National Aeronautics and Space Administration, and National Science Foundation for SBIR/STTR programs must be transferred to the Small Business Administration (SBA) to increase SBA's resources for administering these programs.
Sec. 401(a)(4)(B)
Why it matters:While impactful, this is a specific funding mechanism within a broader section on program administration, making its placement typical for such technical adjustments to existing law. It's a precise amendment to how administrative funds are handled.
Case for: Proponents argue this transfer centralizes and strengthens the SBA's capacity to administer and oversee the entire SBIR/STTR ecosystem, ensuring more consistent program management, data collection, and support services across all participating agencies.
Case against: Agencies subject to this transfer might argue it reduces their own administrative flexibility and capacity to manage their specific SBIR/STTR programs, potentially leading to resource strains within their individual departments.
Estimated impact: This will result in a reallocation of millions of dollars in administrative funds from major R&D agencies to the SBA annually, significantly boosting the SBA's operational budget for SBIR/STTR oversight.
Establishes extensive definitions for 'covered foreign entity' and 'foreign entity of concern,' which are critical for determining eligibility for SBIR awards. These definitions include foreign terrorist organizations, sanctioned entities, entities from 'covered nations' (as defined in 10 U.S.C. 4872), entities involved in espionage or economic espionage, and any person or entity controlled by or acting on behalf of such entities.
Sec. 505(a)(2)(A)
Why it matters:The precise and comprehensive nature of these definitions is necessary for legal clarity and enforceability in national security matters. This is standard legislative practice for complex regulatory frameworks.
Case for: Supporters emphasize that these detailed definitions are essential for robust national security, providing clear legal grounds to prevent foreign adversaries from exploiting federal R&D programs and protecting critical U.S. technologies and intellectual property.
Case against: Some might argue that the breadth and complexity of these definitions could create significant administrative burdens for small businesses and investors, potentially deterring legitimate foreign investment or causing delays in award processing due to extensive vetting requirements.
Estimated impact: These definitions will significantly broaden the scope of entities subject to national security vetting for SBIR awards, impacting a wide range of small businesses with foreign investment ties and requiring substantial due diligence from federal agencies.
Allows the National Institutes of Health (NIH), under its pilot program to accelerate SBIR/STTR awards, to use flexible peer review procedures (including consultation with appropriate scientific experts) that are 'deemed to fulfill any requirements applicable' under sections 406(a)(3)(A) and 492 of the Public Health Service Act. These sections typically govern the scientific peer review of research grants and contracts.
Sec. 504(a)(3)(C)
Why it matters:This is a technical amendment to allow a pilot program to operate with modified review processes without running afoul of existing statutory requirements. Its placement is typical for such waivers or modifications within a pilot program's framework.
Case for: Proponents argue that this flexibility is essential for NIH to achieve its goal of accelerating award times, allowing for more agile and efficient review processes tailored to the specific needs of SBIR/STTR projects without compromising scientific quality.
Case against: Critics might express concern that 'flexible peer review procedures' could potentially reduce the rigor or impartiality of the scientific review process, leading to less meritorious projects being funded or undermining the integrity of NIH's traditional peer review system.
Estimated impact: This provision could significantly alter the scientific review landscape for NIH SBIR/STTR awards during the pilot period, potentially leading to faster funding decisions but also raising questions about the long-term implications for review standards.